Skip to main content

Table 3 Clinical Characteristics and Patient Reported Outcome Measures Based on The Presence of Suicidal Ideation Among Adolescents with Juvenile Fibromyalgia Syndrome (N = 31)

From: Suicidal risk and resilience in juvenile fibromyalgia syndrome: a cross-sectional cohort study

Variables

SI (n = 8)

No SI (n = 23)

p-value

Clinical Characteristics [median (IQR)]

 Pain Duration (months)

10 (5–24)

24 (10–36)

0.22

 Pain VAS (Visual Analog Scale)

64 (60–75)

54 (26–67)

0.04*

 Widespread Pain Index (WPI)

12 (9–13)

11 (9–14)

0.80

 Symptom Severity Score (SSS)

8 (7–10)

8 (7–9)

1.00

Patient Reported Outcome Measures (PROs) [median (IQR)]

 Functional Disability Inventory (FDI) (0–60)

25 (16.5–31)

20 (15–31)

0.46

 PROMIS Global Health 7 (PGH-7)

34 (28–40)

39 (34–42)

0.13

 14-item Resilience Scale (14–98)

58 (43–69)

74 (67–81)

0.02*

 CDI-2 (Depression)

74 (63–83)

55 (51–67)

0.02*

 MASC-2 (Anxiety)

83 (63–89)

63 (50–70)

0.01*

 PedsQL Total Multidimensional Fatigue Scale (MFS) (0–100)

37 (32–43)

39 (28–56)

0.80

 MFS General Fatigue

29 (21–38)

42 (25–54)

0.21

 MFS Sleep

31 (25–52)

42 (29–54)

0.39

 MFS Cognitive

42 (40–63)

38 (25–71)

0.59

 BRIEF-2 Global Executive Composite (GEC) T Score

57 (51–69)

58 (49–71)

1.00

  1. Legend. *<0.05 = Significant p-value. IQR = interquartile range. Differences in characteristics were assessed using Wilcoxon Rank Sum test for continuous variables and Fisher’s Exact test for categorical variables. Pain VAS (visual analog scale) range from 0 to 100 with higher scores indicating more pain. SS scores total between 0 and 12 with higher scores indicating greater severity. WPI score ranges from 0 to 19 with higher values indicating greater involvement of different anatomical regions where the child has experienced pain over the past 7 days. Greater FDI scores indicate more functional disability. 14-item Resilience Scale - greater scores indicate greater resilience (ranging from 14 to 98). The Children’s Depression Inventory, 2nd Edition (CDI-2) is an assessment of depressive symptoms in children and adolescents ages 7–17 years, where T-scores ≥65 identify potentially clinically depressed individuals. The Multidimensional Anxiety Scale for Children, 2nd Edition (MASC-2) is a standardized, 50-item questionnaire assessing anxiety symptoms in adolescents where T-scores ≥60 indicate increased likelihood of at least one anxiety disorder in the subject. The Pediatric Quality of Life Inventory Multidimensional Fatigue Scale (PedsQL MFS) assesses 3 dimensions: general, sleep/rest, and cognitive fatigue. Scores ranges from 0 to 100 where higher scores indicate less symptoms/problems in a dimension. Behavior Rating Inventory of Executive Function-2 (BRIEF-2) is a standardized rating scale used to assess children’s executive functions in home and school environments where T scores from 60 to 64 are considered mildly elevated, and T scores from 65 to 69 are considered potentially clinically elevated
Back to article page

Pediatric Rheumatology

ISSN: 1546-0096